- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Image IQ: 42-year-old Woman with Recent Stage III Malignant Melanoma Diagnosis
A 42- year-old female with recent diagnosis of stage III malignant melanoma in her leg presents for evaluation of a palpable right breast lump.
CLICK on the images to enlarge.
On mammography, in the patient’s area of concern in the right 8:00 position, a well-circumscribed, round mass is seen measuring 5 mm. Just adjacent to this is an additional 10 mm round, well-circumscribed mass. On physical examination, there is a palpable superficial mobile lump in the right 8:00 area of concern. Ultrasound demonstrates a cyst measuring 4 mm, corresponding to the area of concern at 8:00. At the 8:30 position, there is a heterogeneous round mass noted measuring 12 x 9 x 6 mm.
What is your diagnosis?
Abbreviated MRI for Hepatocellular Carcinoma: What a New Meta-Analysis Reveals
January 6th 2025For hepatocellular carcinoma screening, a 19-study meta-analysis found the abbreviated MRI sequencing protocol of T2-weighted MRI, diffusion-weighted imaging (DWI) and hepatobiliary phase (HBP) imaging offered 88 percent sensitivity and 93 percent specificity.
Study Emphasizes PSMA PET Staging of High-Risk, Hormone Sensitive Prostate Cancer
January 4th 2025In patients with high-risk, hormone sensitive prostate cancer who had no evidence of metastasis on conventional imaging, PSMA PET revealed polymetastatic disease in 24 percent of patients and M1 disease staging in 46 percent of patients.
Can MRI and Micro-Ultrasound Guidance Bolster Focal Laser Ablation Outcomes for Prostate Cancer?
January 3rd 2025For patients with localized prostate cancer and PI-RADS 3 or higher lesions, MRI-guided micro-ultrasound multifiber focal laser ablation had an 18 percent recurrence rate at one year, according to newly published research.
New CT and MRI Research Shows Link Between LR-M Lesions and Rapid Progression of Early-Stage HCC
January 2nd 2025Seventy percent of LR-M hepatocellular carcinoma (HCC) cases were associated with rapid growth in comparison to 12.5 percent of LR-4 HCCs and 28.5 percent of LR-4 HCCs, according to a new study.
